World’s first intra-nasal vaccine for COVID gets CDSCO approval for restricted use in emergency situations

World’s first intra-nasal vaccine for COVID gets CDSCO approval for restricted use in emergency situations

• The world’s first intra-nasal vaccine for COVID developed by India has got approval from the Central Drugs Standard Control Organisation for restricted use in emergency situations in the age group of 18 and above.
• India’s efforts through Mission COVID Suraksha has not only strengthened Atmanirbhar Bharat but also bolstered India’s status as a worldwide vaccine development and manufacturing center. There is a  decision to merge the 14 societies of Biotechnology Institutes into a single society in the interest of convenient functioning, cost-effectiveness and integrated working.

November Weekly Current Affairs (Awards) Bitbank: Who has been inducted into the ICC Hall of Fame 2022?

                         >> Download Current Affairs PDFs Here

                              Download Sakshi Education Mobile APP

Published date : 03 Dec 2022 04:55PM